Capricor Therapeutics
CAPR
#7992
Rank
A$0.43 B
Marketcap
A$9.56
Share price
-4.36%
Change (1 day)
-59.02%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$63.96 Million

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are A$63.96 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$40.22 M-24.16%
2023-12-31A$53.03 M-5.79%
2022-12-31A$56.29 M309.67%
2021-12-31A$13.74 M64.61%
2020-12-31A$8.34 M36.74%
2019-12-31A$6.1 M-7.14%
2018-12-31A$6.57 M1.7%
2017-12-31A$6.46 M-79.52%
2016-12-31A$31.56 M34.45%
2015-12-31A$23.47 M-3.36%
2014-12-31A$24.29 M256.81%
2013-12-31A$6.8 M1237.02%
2012-12-31A$0.5 M-3.57%
2011-12-31A$0.52 M-49.83%
2010-12-31A$1.05 M48.29%
2009-12-31A$0.7 M-62.4%
2008-12-31A$1.88 M-12.65%
2007-12-31A$2.16 M1164%
2006-12-31A$0.17 M60.58%
2005-12-31A$0.1 M38.71%
2004-12-31A$0.07 M36.6%
2003-12-31A$0.05 M28.93%
2002-12-31A$0.04 M142.16%
2001-12-31A$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
A$2.94 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$15.19 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.60 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.89 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$75.24 M 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$3.9 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA